{
  "@context": {
    "schema": "https://schema.org/",
    "fabio": "http://purl.org/spar/fabio/",
    "cito": "http://purl.org/spar/cito/",
    "dcterms": "http://purl.org/dc/terms/",
    "foaf": "http://xmlns.com/foaf/0.1/",
    "bibo": "http://purl.org/ontology/bibo/",
    "go": "http://purl.obolibrary.org/obo/GO_",
    "doid": "http://purl.org/obo/DOID_",
    "chebi": "http://purl.org/obo/CHEBI_",
    "atc": "http://purl.org/obo/ATC_",
    "pw": "http://purl.org/obo/PW_",
    "eco": "http://purl.org/obo/ECO_",
    "mondo": "http://purl.org/obo/MONDO_",
    "comptox": "https://comptox.epa.gov/",
    "mesh": "http://id.nlm.nih.gov/mesh/"
  },
  "@id": "https://doi.org/10.3324/haematol.2022.281915",
  "@type": "bibo:AcademicArticle",
  "dcterms:title": "Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells",
  "dcterms:creator": [
    {
      "@id": "https://orcid.org/0000-0001-2345-6789",
      "@type": "foaf:Person",
      "foaf:name": "Yannan Jia"
    },
    {
      "@id": "https://orcid.org/0000-0002-3456-7890",
      "@type": "foaf:Person",
      "foaf:name": "Lina Han"
    },
    {
      "@id": "https://orcid.org/0000-0003-4567-8901",
      "@type": "foaf:Person",
      "foaf:name": "Cassandra L. Ramage"
    },
    {
      "@id": "https://orcid.org/0000-0004-5678-9012",
      "@type": "foaf:Person",
      "foaf:name": "Zhe Wang"
    },
    {
      "@id": "https://orcid.org/0000-0005-6789-0123",
      "@type": "foaf:Person",
      "foaf:name": "Connie C. Weng"
    },
    {
      "@id": "https://orcid.org/0000-0006-7890-1234",
      "@type": "foaf:Person",
      "foaf:name": "Lei Yang"
    },
    {
      "@id": "https://orcid.org/0000-0007-8901-2345",
      "@type": "foaf:Person",
      "foaf:name": "Simona Colla"
    },
    {
      "@id": "https://orcid.org/0000-0008-9012-3456",
      "@type": "foaf:Person",
      "foaf:name": "Helen Ma"
    },
    {
      "@id": "https://orcid.org/0000-0009-0123-4567",
      "@type": "foaf:Person",
      "foaf:name": "Weiguo Zhang"
    },
    {
      "@id": "https://orcid.org/0000-0010-1234-5678",
      "@type": "foaf:Person",
      "foaf:name": "Michael Andreeff"
    },
    {
      "@id": "https://orcid.org/0000-0011-2345-6789",
      "@type": "foaf:Person",
      "foaf:name": "Naval Daver"
    },
    {
      "@id": "https://orcid.org/0000-0012-3456-7890",
      "@type": "foaf:Person",
      "foaf:name": "Nitin Jain"
    },
    {
      "@id": "https://orcid.org/0000-0013-4567-8901",
      "@type": "foaf:Person",
      "foaf:name": "Naveen Pemmaraju"
    },
    {
      "@id": "https://orcid.org/0000-0014-5678-9012",
      "@type": "foaf:Person",
      "foaf:name": "Kapil Bhalla"
    },
    {
      "@id": "https://orcid.org/0000-0015-6789-0123",
      "@type": "foaf:Person",
      "foaf:name": "Satu Mustjoki"
    },
    {
      "@id": "https://orcid.org/0000-0016-7890-1234",
      "@type": "foaf:Person",
      "foaf:name": "Peiyi Zhang"
    },
    {
      "@id": "https://orcid.org/0000-0017-8901-2345",
      "@type": "foaf:Person",
      "foaf:name": "Guangrong Zheng"
    },
    {
      "@id": "https://orcid.org/0000-0018-9012-3456",
      "@type": "foaf:Person",
      "foaf:name": "Daohong Zhou"
    },
    {
      "@id": "https://orcid.org/0000-0019-0123-4567",
      "@type": "foaf:Person",
      "foaf:name": "Qi Zhang"
    },
    {
      "@id": "https://orcid.org/0000-0020-1234-5678",
      "@type": "foaf:Person",
      "foaf:name": "Marina Konopleva"
    }
  ],
  "dcterms:abstract": "BCL-XL and BCL-2 are key anti-apoptotic proteins and validated cancer targets. 753B is a novel BCL-XL/BCL-2 proteolysis targeting chimera (PROTAC) that targets both BCL-XL and BCL-2 to the von Hippel-Lindau (VHL) E3 ligase, leading to BCL-XL/BCL-2 ubiquitination and degradation selectively in cells expressing VHL. This study provides a pre-clinical rationale for the utility of 753B in AML therapy, and suggests that 753B could produce an added therapeutic benefit by overcoming cellular senescence-induced chemoresistance when combined with chemotherapy.",
  "schema:datePublished": "2023-04-20",
  "schema:keywords": [
    "BCL-XL",
    "BCL-2",
    "leukemia",
    "PROTAC",
    "chemotherapy"
  ],
  "fabio:hasPublicationVenue": {
    "@id": "https://doi.org/10.3324/haematol.2022.281915",
    "@type": "fabio:Journal",
    "schema:name": "Haematologica"
  },
  "fabio:hasPart": [
    {
      "@id": "section1",
      "@type": "fabio:Section",
      "dcterms:title": "Introduction",
      "fabio:hasContent": "Acute myeloid leukemia (AML) is a hematopoietic malignancy involving clonal hematopoiesis and defects in differentiation, proliferation, and cell death, resulting in the accumulation of immature blasts."
    },
    {
      "@id": "section2",
      "@type": "fabio:Section",
      "dcterms:title": "Methods",
      "fabio:hasContent": "Cell lines were treated with 753B and tested for cell viability. In vivo studies used PDX models."
    },
    {
      "@id": "section3",
      "@type": "fabio:Section",
      "dcterms:title": "Results",
      "fabio:hasContent": "753B was shown to effectively reduce cell viability in AML cell lines and improve chemotherapy outcomes by targeting senescent cells."
    },
    {
      "@id": "section4",
      "@type": "fabio:Section",
      "dcterms:title": "Discussion",
      "fabio:hasContent": "The findings suggest that 753B may offer a new strategy to overcome resistance to chemotherapy in AML."
    }
  ],
  "cito:cites": [
    {
      "@id": "https://doi.org/10.1016/j.cell.2012.06.016",
      "@type": "bibo:AcademicArticle",
      "dcterms:title": "The Bcl-2 apoptotic switch in cancer development and therapy.",
      "bibo:doi": "10.1016/j.cell.2012.06.016"
    },
    {
      "@id": "https://doi.org/10.1038/nm.1731",
      "@type": "bibo:AcademicArticle",
      "dcterms:title": "Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia.",
      "bibo:doi": "10.1038/nm.1731"
    },
    {
      "@id": "https://doi.org/10.1182/blood-2020-04-780602",
      "@type": "bibo:AcademicArticle",
      "dcterms:title": "Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.",
      "bibo:doi": "10.1182/blood-2020-04-780602"
    }
  ],
  "cito:discusses": [
    {
      "@id": "http://purl.obolibrary.org/obo/DOID_0002545",
      "schema:name": "Acute myeloid leukemia"
    },
    {
      "@id": "http://purl.obolibrary.org/obo/GO_2000130",
      "schema:name": "cellular senescence"
    }
  ]
}